
==== Front
Adv TherAdv TherAdvances in Therapy0741-238X1865-8652Springer Healthcare Cheshire 23010.1007/s12325-015-0230-4ErratumErratum to: Safety and Tolerability of Fingolimod in Latin American Patients with Relapsing-Remitting Multiple Sclerosis: The Open-Label FIRST LATAM Study Ordoñez-Boschetti Laura Rey Roberto Cruz Ana Sinha Arijit Reynolds Tracy Frider Nadina Alvarenga Regina regina_alvarenga@hotmail.com  Consultorio de Medicina Especializada del Sector Privado, Mexico City, Mexico  Instituto Argentino de Investigación Neurológica, Buenos Aires, Argentina  Centro de Investigaciones Médicas Hospital Nacional Alberto Sabogal Sologuren, Callao-Lima, Peru  Novartis Healthcare Pvt. Ltd., Hyderabad, India  Novartis Pharma AG, Basel, Switzerland  Novartis LAtinAmerica and Canada Region, Buenos Aires, Argentina  MS Hospital Da Lagoa, Rio de Janeiro, Brazil 28 7 2015 28 7 2015 2015 32 7 636 636 © The Author(s) 2015issue-copyright-statement© Springer Healthcare 2015
==== Body
Erratum to: Adv Ther DOI 10.1007/s12325-015-0224-2
The authors of the above mentioned paper would like to make the following correction to the author list.

Laura Ordoñez-Boschetti · Roberto Rey · Ana Cruz · Arijit Sinha · Tracy Reynolds · Nadina Frider · Regina Alvarenga


The original article has been updated accordingly.

The online version of the original article can be found under doi:10.1007/s12325-015-0224-2.

Open Access
This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.
